Completed NA INTERVENTIONAL 2-arm NCT00462020

Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis

Sponsor: Children's Mercy Hospital Kansas City

Interventions 5 days of IV antibiotics (ceftriaxone and metronidazole) Home with oral antibiotics when eating (ampicillin/clavulanic acid)

Updated 8 times since 2017 Last updated: Feb 3, 2021 Started: Mar 31, 2007 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00462020, this NA trial focuses on Perforated Appendicitis and remains completed. Sponsored by Children's Mercy Hospital Kansas City, it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Mar 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2021 — Mar 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Mercy Hospital Kansas City

Data source: Children's Mercy Hospital Kansas City

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kansas City, United States